[From effective to economical. The value of good osteoporosis therapy].
Minne
H W
HW
Institut für klinische Osteologie, Klinik Der Fürstenhof, Bad Pyrmont.
Pfeifer
M
M
Pollähne
W
W
D002118:Calcium / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000191:economics; D020849:Raloxifene Hydrochloride / Q000191:economics / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000191:economics / Q000627:therapeutic use*; D014807:Vitamin D / Q000191:economics / Q000627:therapeutic use*
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D020849:Raloxifene Hydrochloride; D002118:Calcium